I have been thinking about buprenorphine, naltrexone and the stimulants cocaine and methamphetamine. An issue which came to my mind recently and which I think it worth discussing is that cocaine is often cut and replaced with fentanyl to hide the over-dilution. This is sometimes done sloppily leading to fentanyl overdoses of people who did […]
If it is not Medicare Advantage plans over-charges tapping into Medicare funds designated for the care of seniors, it is the commercial healthcare companies such as pharma this time and again. The political influence these companies wield with legislators and probably SCOTUS justices (later as companies sue and quickly levitate to a SCOTUS hearing) who […]
Pharma’s strike-from-all-sides attack on the IRA could be decided by the Supreme Court, PharmaVoice, Alexandra Pecci Pharma Voice reports Merck & Company and Bristol Myers Squibb in separate lawsuits are filing a multi-directional attack on Biden’s IRA using the first and fifth amendment as the basis for their filing. Industry lobbyists and co-litigants have joined […]
Delightful story on how US pharmaceutical companies shift profits overseas. And US citizens are paying the highest prices globally for lifesaving meds which other countries our paying roughly one third. Pharma is also shifting their profits overseas and minimizing US taxes or tax avoidance. One way to avoid taxes is to move intellectual property to […]
This is an abbreviated version of a Canadian trial which examines whether eliminating out-of-pocket costs would improve the health of people taking the medications by making drugs less costly. The greater impact was amongst lower income participants who may not take drugs as prescribed to lengthen a refill timetable. The elimination of out-of-pocket medication costs […]
Earlier this year, one company’s closing is adding to national pharmaceutical shortages and capacity in its bankruptcy. The closing can be construed as more than just allowing a laissez-faire economic policy. There are greater healthcare implications for the US. The nation can rescue banks, companies such as AIG, and those gambling with CDS, countering naked […]
This commentary came by way of ltr a reader at Angry Bear. A pretty solid review of how drug prices and the resulting costs after insurance are still impossible to pay. That is, if the insurance, Medicare, Medicaid even pay for them in entirety or a portion. If the former is not the case, a […]
What I like about this Issue-Brief is the use of terminology we see, not knowing what it means, and seeing a description or definition. I have added links so as to do a deeper dive into the terminology. Carefully read, a person can garner an understanding of initial drug costs, intermediate costs, discounts, and what […]
Commenter Arne asked how we would transition from today’s healthcare system to a Single Payer format. I do not have the answer immediately at hand. I have to look for it. I do want to review what we have learned to date and stated on Angry Bear already. I do have a number of posts […]
Medicare is almost $200 billion in gross drug spend: Who gets the blame? — 46brooklyn Research This is a complex issue as there are many moving parts to drug pricing and their costs. Perplexing in describing the drug spend issues would seem appropriate. I am not even sure if this long post will adequately define […]